Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Neutral

Price to Earnings Rating

Sell

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Edwards Lifesciences Corp (EW)

Orthopedic, Prosthetic & Surgical Appliances & Supplies

https://www.edwards.com

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

ONE EDWARDS WAY
IRVINE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/03/2000

Market Cap

41,671,020,000

Shares Outstanding

606,500,000

Weighted SO

606,500,000

Total Employees

N/A

Upcoming Earnings

07/24/2024

Beta

1.1110

Last Div

0.0000

Range

58.93-96.12

Chg

1.0550

Avg Vol

4698516

Mkt Cap

41671020000

Exch

NYSE

Country

US

Phone

949 250 2500

DCF Diff

22.4155

DCF

46.6045

Div Yield

0.0000

P/S

6.9462

EV Multiple

23.6474

P/FV

5.6001

Div Yield %

0.0000

P/E

28.2758

PEG

3.2688

Payout

0.0000

Current Ratio

3.7108

Quick Ratio

2.8688

Cash Ratio

1.3541

DSO

50.7669

DIO

269.2115

Op Cycle

319.9784

DPO

48.8401

CCC

271.1384

Gross Margin

0.7684

Op Margin

0.2702

Pretax Margin

0.2762

Net Margin

0.2455

Eff Tax Rate

0.1124

ROA

0.1459

ROE

0.2115

ROCE

0.1825

NI/EBT

0.8890

EBT/EBIT

1.0223

EBIT/Rev

0.2702

Debt Ratio

0.0613

D/E

0.0832

LT Debt/Cap

0.0743

Total Debt/Cap

0.0768

Int Coverage

58.3058

CF/Debt

1.3996

Equity Multi

1.3579

Rec Turnover

7.1897

Pay Turnover

7.4734

Inv Turnover

1.3558

FA Turnover

3.4619

Asset Turnover

0.5940

OCF/Share

1.4385

FCF/Share

0.8944

Cash/Share

3.3106

OCF/Sales

0.1444

FCF/OCF

0.6218

CF Coverage

1.3996

ST Coverage

40.2837

CapEx Coverage

2.6438

Div&CapEx Cov

2.6438

P/BV

5.6001

P/B

5.6001

P/S

6.9462

P/E

28.2758

P/FCF

77.3835

P/OCF

48.0894

P/CF

48.0894

PEG

3.2688

P/S

6.9462

EV Multiple

23.6474

P/FV

5.6001

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 12, 04:15 UK leads G7 countries in addressing child sexual violence, but ODA cuts are hurting progress GlobeNewswire Inc. May 15, 22:52 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, XAGE, SSBK on Behalf of Shareholders GlobeNewswire Inc. May 12, 22:55 HighPeak Energy, Inc. Announces First Quarter 2025 Financial and Operating Results - AMENDED GlobeNewswire Inc. May 10, 15:00 Energy Storage System Market Size to worth USD 86.76 Bn by 2032, Driven by Renewable Energy Boom GlobeNewswire Inc. Apr 07, 22:00 European Wax Center, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Apr 06, 20:12 Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights Benzinga Apr 04, 19:47 Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry Benzinga Apr 04, 04:05 South Korea's Yoon Suk Yeol Removed, Court Says President 'Committed A Grave Betrayal' Benzinga Apr 03, 21:23 Mexican Stocks Notch Widest 1-Day Rally Versus S&P 500 Since 1998 As Trump Spares Mexico From Tariffs GlobeNewswire Inc. Apr 03, 01:23 Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Mar 29, 15:55 Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Mar 21, 20:50 SaverOne Reports Full Year 2024 Results GlobeNewswire Inc. Mar 13, 22:44 Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Mar 09, 22:59 Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Mar 03, 23:42 Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Feb 25, 23:00 Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Feb 19, 23:11 Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Feb 08, 17:55 Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Feb 02, 20:02 Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Jan 30, 23:35 Dave Inc. Announcement: If You Have Suffered Losses in Dave Inc. (NASDAQ: DAVE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Revenue Product Segmentation